SKAN Group completed the acquisition of a 76% stake in Metronik.

SKAN Group, an isolator for biopharmaceutical production, completed the acquisition of a 76% stake in Metronik, an automation and digitalization solutions provider. Financial terms were not disclosed. “The integration of Metronik is another milestone in the digitalization of SKAN's offering. Seamless integration into our customers' production processes enables us to increase their efficiency along the entire value chain,” Thomas Huber, SKAN Group CEO.